Why is Tesla stock plunging after Musk’s political move?
How will Trump’s new tariffs impact global trade?
What caused the rise in Amazon Prime Day sales forecast?
Why is Dow closing European plants and cutting jobs?
How are ransomware groups escalating attacks on retailers?
What’s behind Capgemini’s $3.3B acquisition of WNS?
How is AI reshaping finance and investment banking?
Eli Lilly's 3-step strategy to dominate the $95 billion obesity market
businessinsider.com/eli-lilly-3-step-strategy-dominate-95-billion-obesity-market-2025-7
Scientists at Eli Lilly are racing to develop new weight loss drugs that will be cheaper, stronger, or preserve more muscle mass.
Eli Lilly
Eli Lilly has outpaced Ozempic-maker Novo Nordisk in the race to develop new incretin drugs.
The company is set to capture 50% of the $95 billion…
This story appeared on businessinsider.com, 2025-07-07 09:30:01.